The role of cholinergic mechanisms in the corticofugal inhibition of the spinal trigeminal nucleus.
D000344:Afferent Pathways / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology*; D003913:Dextroamphetamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004569:Electroencephalography; D009433:Neural Inhibition / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000502:physiology*; D013116:Spinal Cord / Q000187:drug effects / Q000502:physiology*; D014276:Trigeminal Nerve / Q000187:drug effects / Q000502:physiology*
D011950:Receptors, Cholinergic; D001285:Atropine; D010830:Physostigmine; D003913:Dextroamphetamine